We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.54B
1-Year Est. Return 86.39%
This Fund
S&P 500
This Quarter Est. Return
-4.39%
1 Year Est. Return
+86.39%
3 Year Est. Return
-13.28%
5 Year Est. Return
-50.7%
10 Year Est. Return
+414.55%
AUM
$843M
AUM Growth
-$681M
Cap. Flow
-$665M
Cap. Flow %
-78.85%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$637M
2
DNLI icon
Denali Therapeutics
DNLI
+$28M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$57.4B
$550M 65.22%
4,632,149
-5,033,889
-52% -$637M
SANA icon
2
Sana Biotechnology
SANA
$946M
$137M 16.19%
25,001,856
– –
FHTX icon
3
Foghorn Therapeutics
FHTX
$245M
$72.9M 8.64%
12,674,120
– –
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$60.5M 7.17%
29,225,579
– –
MCRB icon
5
Seres Therapeutics
MCRB
$46.2M
$16.7M 1.98%
1,155,852
– –
SYRS
6
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$6.68M 0.79%
1,293,849
– –
DNLI icon
7
Denali Therapeutics
DNLI
$3.26B
– –
-1,364,516
Closed -$28M

Similar funds

SPC
Stony Point Capital New York $1.54B AUM 54.05% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
SMC
Smith, Moore & Co Clayton, Missouri $1.54B AUM 24.82% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
BOF
Bank of Finland Helsinki, Finland $1.54B AUM 15.84% 1-Year Est. Return
KCM
Kanawha Capital Management Richmond, Virginia $1.54B AUM 21.3% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.54B AUM 27.61% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Flagship Pioneering's Q2 2024 Portfolio in Review

As of Q2 2024, Flagship Pioneering held 7 positions worth $843M, down 45% from $1.52B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $665M in Q2 2024, closing 1 position and reducing 1 holding. Its most notable exit was Denali Therapeutics, an estimated $28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's biggest Q2 2024 reduction was Moderna, cutting an estimated $637M.
  • Flagship Pioneering fully exited Denali Therapeutics in Q2 2024, selling an estimated $28M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $843M portfolio in Q2 2024.
  • Flagship Pioneering opened 0 new positions and closed 1 in Q2 2024.
  • Flagship Pioneering's portfolio value fell 45% quarter-over-quarter to $843M.

Based on Flagship Pioneering's 13F filing for Q2 2024, filed 14 Aug 2024.